[REVISION HISTORY]

Brazil public health and immunization initiatives

Updated 26 times since CLSTR started tracking revisions of this situation.

What changed

2026-10-22 02:22 UTC → 2026-10-26 20:02 UTC · added ~~removed~~

Brazil’s Unified Health System (SUS) has implemented several public health initiatives focused on disease prevention and immunization. In early September 2026, SUS launched the ‘Para cada hepatite, tem um cuidado’ campaign to improve the prevention, diagnosis, and treatment of hepatitis A, B, C, and D. This follows 2025 epidemiological data showing high hepatitis A incidence among adults aged 25 to 34 and significant hepatitis C concentrations in men aged 60 or older. Regarding pneumococcal disease, the Ministry of Health reported that over 1 million children under five were vaccinated with the new Pneumo 20 vaccine by mid-September 2026. This rollout aims to combat severe pneumonia and meningitis, addressing a period between 2023 and 2025 that saw 4,600 cases of pneumococcal meningitis and a 30% lethality rate. The Pneumo 20 vaccine is gradually replacing the Pneumo 10 version as it is incorporated into the National Vaccination Calendar. ~~By mid-October~~ Throughout late September and October 2026, ~~access to Pneumo 20~~ the rollout expanded significantly to include elderly populations. In Alagoas, availability was extended to children under five, unvaccinated indigenous peoples aged 5 and older, and specific elderly groups, including those aged 60 to 84 who are bedridden or institutionalized, as well as populations, specifically targeting residents aged 85 and older. ~~In various municipalities~~ Municipalities such as ~~Rio~~ Araguaína, Goiânia, São Gonçalo, João Pessoa, Curitiba, Limeira, Juiz de ~~Janeiro, Guarulhos,~~ Fora, Porto Alegre, and ~~Cuiabá, the vaccine has been rolled out~~ Canela have implemented local administration programs. In many regions, including Maceió and Juiz de Fora, health officials are providing home visits for bedridden or institutionalized seniors to ~~seniors, with~~ facilitate access. Vaccination protocols ~~varying~~ vary based on ~~previous~~ prior immunization ~~history.~~ history; for instance, those previously vaccinated with Pneumo 13 or 15 may require specific intervals before receiving Pneumo 20. Additionally, Anvisa approved Capvaxive, a 21-valent conjugate vaccine for adults aged 18 and older, though ~~no specific date for~~ its availability via SUS ~~or private clinics has been set. On October 21, 2026, local health efforts continued with the administration of the Pneumo 20 vaccine to residents at the Casa do Idoso Sagrado Coração de Jesus.~~ remains unconfirmed.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.